Use of a multimeric anti-DR5 binding molecule in combination with a chemotherapeutic agent for treating cancer

• 收藏
• 分享

专利权人:

IGM Biosciences; Inc.

发明人:

WANG, Beatrice Tien-Yi,KEYT, Bruce Alan

申请号：

AU2019224136

公开号：

AU2019224136A1

申请日:

2019.02.25

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

This disclosure provides therapeutic methods for treating cancer including combination therapy with a multimeric anti-DR5 antibody and a chemotherapeutic agent, e.g., a type I topoisomerase inhibitor, a nucleoside analog, or a pro-apoptotic agent, e.g., a BCL-2 inhibitor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/